While under competitive pressure from Novartis and Eli Lilly, Pfizer can tally up a unique trial win for its Ibrance in a ...
The benefit of the PARP inhibitor in patients with germline BRCA pathogenic variants remains evident 10 years after the first ...
Meta-analysis of three trials found that immediate breast surgery in women over 70 cut breast cancer death rates in half ...
The findings from the study demonstrated a substantial decrease in reoperation rates when the Histolog scanner was utilised.
Receiving immediate surgery was associated with a reduction in local recurrence of breast cancer in elderly patients versus delaying surgery.
Interim overall survival (OS) analyses at 31% maturity in patients with ESR1 mutations, and 23% maturity among all patients, ...
Patients with ER-positive/HER2-negative metastatic breast cancer who received elacestrant experienced a significant reduction ...
Imlunestrant, an investigational next-generation selective estrogen receptor degrader (SERD), improved progression-free ...
Immediate surgery can improve outcomes among women age 70 and older who are not receiving radiotherapy, data suggest.
Patients with high-risk, BRCA-positive breast cancer who received olaparib (Lynparza) after standard treatment continued to have better survival outcomes than those who received placebo after a median ...
Patients with high-risk, BRCA-positive breast cancer who received olaparib (Lynparza) after standard treatment continued to ...
The company found that the 1 mg dose of Z-endoxifen reduced MBD by 17.3 percentage points, whereas the 2 mg dose achieved a reduction of 23.5 percentage points. Meanwhile, a minimal change of 0.27 ...